Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Profound Medical (PROF) EBIAT (2024 - 2025)

Profound Medical has reported EBIAT over the past 2 years, most recently at -$8.2 million for Q4 2025.

  • Quarterly results put EBIAT at -$8.2 million for Q4 2025, down 65.25% from a year ago — trailing twelve months through Dec 2025 was -$42.6 million (down 53.05% YoY), and the annual figure for FY2025 was -$42.6 million, down 53.04%.
  • EBIAT for Q4 2025 was -$8.2 million at Profound Medical, down from -$8.0 million in the prior quarter.
  • Over the last five years, EBIAT for PROF hit a ceiling of -$4.9 million in Q4 2024 and a floor of -$15.7 million in Q2 2025.